End-of-day quote
Shanghai S.E.
06:00:00 2024-05-06 pm EDT
|
5-day change
|
1st Jan Change
|
8.17
CNY
|
-2.16%
|
|
-0.49%
|
+16.55%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
26,006
|
33,241
|
26,919
|
24,052
|
26,691
|
31,107
|
-
|
-
|
Enterprise Value (EV)
1 |
28,388
|
36,125
|
29,021
|
21,882
|
24,319
|
40,352
|
43,667
|
31,107
|
P/E ratio
|
15.4
x
|
11.7
x
|
11.6
x
|
12.2
x
|
12.7
x
|
14.1
x
|
10.5
x
|
11.3
x
|
Yield
|
-
|
2.75%
|
2.04%
|
3.83%
|
3.57%
|
3.06%
|
4.27%
|
-
|
Capitalization / Revenue
|
0.26
x
|
0.3
x
|
0.22
x
|
0.17
x
|
0.18
x
|
0.18
x
|
0.16
x
|
0.14
x
|
EV / Revenue
|
0.29
x
|
0.33
x
|
0.24
x
|
0.16
x
|
0.16
x
|
0.24
x
|
0.23
x
|
0.14
x
|
EV / EBITDA
|
10
x
|
7.36
x
|
6.93
x
|
6.21
x
|
6.5
x
|
7.4
x
|
7.1
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.42
x
|
1.75
x
|
1.31
x
|
1.09
x
|
1.14
x
|
1.38
x
|
1.15
x
|
1.31
x
|
Nbr of stocks (in thousands)
|
3,833,850
|
3,818,311
|
3,814,733
|
3,847,610
|
3,807,514
|
3,807,514
|
-
|
-
|
Reference price
2 |
6.783
|
8.706
|
7.057
|
6.251
|
7.010
|
8.170
|
8.170
|
8.170
|
Announcement Date
|
4/28/20
|
4/26/21
|
4/25/22
|
4/24/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
99,497
|
110,860
|
122,407
|
140,424
|
150,140
|
170,336
|
190,955
|
225,315
|
EBITDA
1 |
2,838
|
4,909
|
4,187
|
3,526
|
3,741
|
5,456
|
6,151
|
-
|
EBIT
1 |
2,301
|
4,352
|
3,593
|
2,853
|
3,023
|
3,657
|
4,785
|
5,228
|
Operating Margin
|
2.31%
|
3.93%
|
2.93%
|
2.03%
|
2.01%
|
2.15%
|
2.51%
|
2.32%
|
Earnings before Tax (EBT)
1 |
2,317
|
4,334
|
3,363
|
2,838
|
2,991
|
3,614
|
4,369
|
5,195
|
Net income
1 |
1,727
|
3,075
|
2,448
|
2,085
|
2,174
|
2,550
|
3,180
|
3,642
|
Net margin
|
1.74%
|
2.77%
|
2%
|
1.48%
|
1.45%
|
1.5%
|
1.67%
|
1.62%
|
EPS
2 |
0.4410
|
0.7430
|
0.6088
|
0.5129
|
0.5500
|
0.5800
|
0.7787
|
0.7200
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.2397
|
0.1438
|
0.2397
|
0.2500
|
0.2500
|
0.3492
|
-
|
Announcement Date
|
4/28/20
|
4/26/21
|
4/25/22
|
4/24/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
35,776
|
40,472
|
41,151
|
44,581
|
51,439
|
38,161
|
45,793
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,323
|
1,418
|
1,608
|
1,313
|
1,527
|
EBIT
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
614.6
|
665.4
|
1,142
|
1,237
|
1,427
|
1,070
|
1,283
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.72%
|
1.64%
|
2.77%
|
2.77%
|
2.77%
|
2.8%
|
2.8%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
618.7
|
661.8
|
925.8
|
1,003
|
1,157
|
886.7
|
1,064
|
Net income
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
350.4
|
537.7
|
704.8
|
763.6
|
881.1
|
675.1
|
810.1
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.98%
|
1.33%
|
1.71%
|
1.71%
|
1.71%
|
1.77%
|
1.77%
|
EPS
2 |
0.0192
|
0.1103
|
0.2061
|
0.1150
|
0.0815
|
0.1390
|
0.2000
|
-
|
0.1400
|
0.2300
|
0.1900
|
0.2100
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.3706
|
-
|
-
|
-
|
0.3875
|
Announcement Date
|
4/25/22
|
4/25/22
|
8/22/22
|
10/24/22
|
4/24/23
|
4/24/23
|
8/28/23
|
4/26/24
|
4/27/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
2,381
|
2,884
|
2,102
|
-
|
-
|
9,245
|
12,560
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
2,170
|
2,372
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.8391
x
|
0.5876
x
|
0.5021
x
|
-
|
-
|
1.694
x
|
2.042
x
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
9.32%
|
15.9%
|
11.4%
|
8.98%
|
9.04%
|
10%
|
11.2%
|
11.6%
|
ROA (Net income/ Total Assets)
|
2.51%
|
4.05%
|
2.94%
|
2.34%
|
-
|
2.6%
|
2.75%
|
-
|
Assets
1 |
68,924
|
75,984
|
83,379
|
89,104
|
-
|
98,096
|
115,639
|
-
|
Book Value Per Share
2 |
4.790
|
4.960
|
5.370
|
5.750
|
6.140
|
5.910
|
7.110
|
6.230
|
Cash Flow per Share
2 |
0.7100
|
0.8800
|
0.8800
|
1.020
|
1.210
|
0.9700
|
1.380
|
-0.1000
|
Capex
1 |
1,175
|
1,158
|
1,215
|
1,083
|
885
|
1,056
|
1,363
|
-
|
Capex / Sales
|
1.18%
|
1.04%
|
0.99%
|
0.77%
|
0.59%
|
0.62%
|
0.71%
|
-
|
Announcement Date
|
4/28/20
|
4/26/21
|
4/25/22
|
4/24/23
|
4/26/24
|
-
|
-
|
-
|
Last Close Price
8.17
CNY Average target price
10.18
CNY Spread / Average Target +24.66% Consensus |
1st Jan change
|
Capi.
|
---|
| +16.55% | 4.41B | | +17.88% | 70.09B | | -1.07% | 24.01B | | +8.01% | 8.32B | | -18.28% | 8.23B | | 0.00% | 8.08B | | +4.40% | 4.68B | | -0.70% | 4.12B | | -2.20% | 3.88B | | +26.24% | 3.71B |
Pharmaceuticals Wholesale
|